Formulation and Delivery – Chemical
Rene Holm, PhD
Professor
University of Southern Denmark
Odense, Syddanmark, Denmark
Patient-centricity and user-friendliness are fast-becoming key drivers of innovation in drug development. Drug product design first has to take into consideration patient needs, benefits, and specific disease-driven limitations on how the drug product is going to be used by the patient. This theme focuses on patient perspectives on the convenience of administration, non-invasive route of administration, reducing dosing burden, and achieving targeted delivery of new modalities by using sustained-release products, long-acting injectable, IV pump, transdermal patch, microneedle, and nanomedicines to address the needs of specific patient populations such as pediatrics, geriatrics, dysphagia patients, or the cognitively impaired.